Blog Posts

Why Protocol Complexity Is Slowing First Patient In – And How Small Sponsors Can Fix Start-Up Inefficiencies

By Jessica Cordes - July 23, 2026

Guest Column | July 23, 2026 Why Protocol Complexity Is Slowing First Patient In - And How Small Sponsors Can Fix Start-Up Inefficiencies By Jessica Cordes, senior consultant, Clinical Excellence GmbH Clinical trial start-up inefficiencies are rarely caused by a

Uncategorized

Everything To Know About Long-Term Data Collection For Cell And Gene Therapy Trials In The EU

Clinical Leader

From Tissue Donation To Distribution: Understanding EU Regulatory Requirements In Cell Therapy Clinical Trials

Clinical Leader

FDA Provides Updated Draft Guidance To Support E6(R3)

Clinical Leader

What Does It Mean To Be “Underserved”?

Clinical Leader

How Changes To The Declaration Of Helsinki Impact Clinical Trials

Clinical Leader

An Expert Guide To Effective Sponsor Oversight In Clinical Trials

I'm Jessica Cordes

I am a professional in Clinical Operations dedicated to helping you as a small Company

to conduct successful First-In-Human Clinical Trials and develop your Organization to abhiebe your Drug Development Goals.

With a Master's degree in Molecular Life Science and over 15 years of experience in Clinical Trials, whereas over 12 years in Oncology and

over 6 years in Cell and Gene Therapy, I have honed my skills in areas such as

Protocol Design, Site Selection and Site Feasibility, Patient Recruitment, as well as

Organizational Development and Leadership.

Why Protocol Complexity Is Slowing First Patient In – And How Small Sponsors Can Fix Start-Up Inefficiencies

23.07.2026

Clinical Leader

Aligning AI Use Clinical Trials With FDA And EMA Expectations

07.05.2026

Let's Connect

Book a Meeting

Elevate Your Clinical Excellence!

Unlock the power of spotlighted information delivery

via my bi-weekly newsletter Clinical Operations Spotlight